Exact Sciences
EXAS
#1881
Rank
โ‚ฌ8.17 B
Marketcap
44,03ย โ‚ฌ
Share price
-2.60%
Change (1 day)
-19.36%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -โ‚ฌ0.97 Billion

According to Exact Sciences's latest financial reports the company's current earnings are โ‚ฌ2.75 Billion. a decrease over its 2023 earnings that were of -โ‚ฌ0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ0.97 Billion435.08%
2023 -โ‚ฌ0.19 Billion-69.28%
2022 -โ‚ฌ0.59 Billion-25.55%
2021 -โ‚ฌ0.79 Billion1.68%
2020 -โ‚ฌ0.78 Billion271.17%
2019 -โ‚ฌ0.21 Billion58.99%
2018 -โ‚ฌ0.14 Billion20.89%
2017 -โ‚ฌ0.11 Billion-30.95%
2016 -โ‚ฌ0.16 Billion5.09%
2015 -โ‚ฌ0.15 Billion57.24%
2014 -โ‚ฌ95.3 Million116.53%
2013 -โ‚ฌ44.01 Million
2011 -โ‚ฌ27.4 Million143.73%
2010 -โ‚ฌ11.25 Million27.85%
2009 -โ‚ฌ8.8 Million0.27%
2008 -โ‚ฌ8.77 Million-20.95%
2007 -โ‚ฌ11.1 Million-13.53%
2006 -โ‚ฌ12.83 Million-10.07%
2005 -โ‚ฌ14.27 Million-21.81%
2004 -โ‚ฌ18.25 Million-33.44%
2003 -โ‚ฌ27.42 Million-6.51%
2002 -โ‚ฌ29.33 Million17.95%
2001 -โ‚ฌ24.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.11 Billion-88.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ62.62 M-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ7.77 Million-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ33.24 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.54 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France